Modulation of Mesolimbic Dopaminergic Behaviors by Cholecystokinin
- 1 October 1988
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 537 (1) , 380-396
- https://doi.org/10.1111/j.1749-6632.1988.tb42121.x
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Distribution of Cholecystokinin‐like Immunoreactivity in the Nervous SystemAnnals of the New York Academy of Sciences, 1985
- Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the ratBrain Research, 1985
- Cholecystokinin tetrapeptide, proglumide and open-field behavior in ratsLife Sciences, 1984
- Pharmacological study on the mixed CCK8/DA meso-nucleus accumbens pathway: Evidence for the existence of storage sites containing the two transmittersBrain Research, 1984
- Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disordersLife Sciences, 1984
- The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of ratNeuroscience Letters, 1984
- Characterization of Cholecystokinin Binding Sites in Rat Cerebral Cortex Using a 125I‐CCK‐8 Probe Resistant to DegradationJournal of Neurochemistry, 1983
- Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesionsLife Sciences, 1983
- Brain Peptides as NeurotransmittersScience, 1980
- Evidence for coexistence of dopamine and CCK in meso-limbic neuronesNature, 1980